The concentration of brain homogenates with the Amicon Ultra Centrifugal filters

Accurately measuring the brain concentration of a neurotherapeutic is critical in determining its pharmacokinetic profile in vivo. Biologics are potential therapeutics for neurologic diseases and biologics fused to an antibody targeting a transcytosis receptor at the Blood-Brain Barrier, designated...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Joshua Yang, Rachita K. Sumbria
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/2b15fcb42d1443af8720d69815bb034a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2b15fcb42d1443af8720d69815bb034a
record_format dspace
spelling oai:doaj.org-article:2b15fcb42d1443af8720d69815bb034a2021-11-24T04:31:21ZThe concentration of brain homogenates with the Amicon Ultra Centrifugal filters2215-016110.1016/j.mex.2021.101584https://doaj.org/article/2b15fcb42d1443af8720d69815bb034a2021-01-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2215016121003745https://doaj.org/toc/2215-0161Accurately measuring the brain concentration of a neurotherapeutic is critical in determining its pharmacokinetic profile in vivo. Biologics are potential therapeutics for neurologic diseases and biologics fused to an antibody targeting a transcytosis receptor at the Blood-Brain Barrier, designated as antibody-biologic fusion proteins, are Blood-Brain Barrier penetrating neurotherapeutics. The use of sandwich immunosorbent assays to measure concentrations of antibody-biologic fusion proteins in brain homogenates has become increasingly popular. The raw brain homogenate contains many proteins and other macromolecules that can cause a matrix effect, potentially interfering with the limit of detection of such assays and reduce the overall sample signal. Further, the low sample loading volumes while running these assays can reduce the sample signal. Our aim was therefore to optimize the existing tissue sample preparation and processing to concentrate the sample to elevate the signal of the analyte. Here, we present a protocol for concentrating and increasing the signal of transferrin receptor antibody-biologic fusion proteins in mouse brain homogenates using the Amicon Ultra Centrifugal filters.• The presented method uses the Amicon Ultra Centrifugal filters to concentrate mouse brain tissue homogenates.• The concentrated brain tissue homogenates are then assayed using standard sandwich enzyme-linked immunosorbent assay (ELISA) protocols.• This method improves upon the traditional brain homogenization procedure and ELISA measurements for antibody-biologic fusion proteins by effectively concentrating brain tissue homogenates.Joshua YangRachita K. SumbriaElsevierarticleBrain concentrationPharmacokineticsBlood-Brain Barrier (BBB)Enzyme-linked immunosorbent assay (ELISA)ScienceQENMethodsX, Vol 8, Iss , Pp 101584- (2021)
institution DOAJ
collection DOAJ
language EN
topic Brain concentration
Pharmacokinetics
Blood-Brain Barrier (BBB)
Enzyme-linked immunosorbent assay (ELISA)
Science
Q
spellingShingle Brain concentration
Pharmacokinetics
Blood-Brain Barrier (BBB)
Enzyme-linked immunosorbent assay (ELISA)
Science
Q
Joshua Yang
Rachita K. Sumbria
The concentration of brain homogenates with the Amicon Ultra Centrifugal filters
description Accurately measuring the brain concentration of a neurotherapeutic is critical in determining its pharmacokinetic profile in vivo. Biologics are potential therapeutics for neurologic diseases and biologics fused to an antibody targeting a transcytosis receptor at the Blood-Brain Barrier, designated as antibody-biologic fusion proteins, are Blood-Brain Barrier penetrating neurotherapeutics. The use of sandwich immunosorbent assays to measure concentrations of antibody-biologic fusion proteins in brain homogenates has become increasingly popular. The raw brain homogenate contains many proteins and other macromolecules that can cause a matrix effect, potentially interfering with the limit of detection of such assays and reduce the overall sample signal. Further, the low sample loading volumes while running these assays can reduce the sample signal. Our aim was therefore to optimize the existing tissue sample preparation and processing to concentrate the sample to elevate the signal of the analyte. Here, we present a protocol for concentrating and increasing the signal of transferrin receptor antibody-biologic fusion proteins in mouse brain homogenates using the Amicon Ultra Centrifugal filters.• The presented method uses the Amicon Ultra Centrifugal filters to concentrate mouse brain tissue homogenates.• The concentrated brain tissue homogenates are then assayed using standard sandwich enzyme-linked immunosorbent assay (ELISA) protocols.• This method improves upon the traditional brain homogenization procedure and ELISA measurements for antibody-biologic fusion proteins by effectively concentrating brain tissue homogenates.
format article
author Joshua Yang
Rachita K. Sumbria
author_facet Joshua Yang
Rachita K. Sumbria
author_sort Joshua Yang
title The concentration of brain homogenates with the Amicon Ultra Centrifugal filters
title_short The concentration of brain homogenates with the Amicon Ultra Centrifugal filters
title_full The concentration of brain homogenates with the Amicon Ultra Centrifugal filters
title_fullStr The concentration of brain homogenates with the Amicon Ultra Centrifugal filters
title_full_unstemmed The concentration of brain homogenates with the Amicon Ultra Centrifugal filters
title_sort concentration of brain homogenates with the amicon ultra centrifugal filters
publisher Elsevier
publishDate 2021
url https://doaj.org/article/2b15fcb42d1443af8720d69815bb034a
work_keys_str_mv AT joshuayang theconcentrationofbrainhomogenateswiththeamiconultracentrifugalfilters
AT rachitaksumbria theconcentrationofbrainhomogenateswiththeamiconultracentrifugalfilters
AT joshuayang concentrationofbrainhomogenateswiththeamiconultracentrifugalfilters
AT rachitaksumbria concentrationofbrainhomogenateswiththeamiconultracentrifugalfilters
_version_ 1718415966061199360